Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Sopra Steria Group: Looking beyond 2017, and no big concerns on SSCL

BUY, Fair Value EUR130 vs. EUR121 (+13%)

Published last May Friday 27, 2016

Roche: GALLIUM positive is very good news for Gazyva and CD20 franchise

BUY, Fair Value CHF293 (+16%)

Published last May Friday 27, 2016

Business services Worth being selective, EUROFINS coverage initiated

Published last May Friday 27, 2016

Nestlé: More savings to come

BUY, Fair Value CHF80 (+9%)

Published last May Thursday 26, 2016

Pennon Group: 2015/16 earnings - first take: in line thanks to Viridor and Bournemouth

SELL, Fair Value  825p (0%)

Published last May Wednesday 25, 2016

Groupe SEB: Conference Call Feedback: how WMF will transform Groupe SEB

BUY, Fair Value Under Review

Published last May Wednesday 25, 2016
Bryan, Garnier & Co advises Aspediens’ shareholders on the Sale of the company to CSC

Bryan, Garnier & Co advises Aspediens’ shareholders on the Sale of the company to CSC

Published last May Tuesday 24, 2016

Shire PLC: A rare opportunity!

BUY Coverage initiated, Fair Value 5900p (+38%)

Published last May Monday 23, 2016

Bayer: Bayer bids for Monsanto for USD62bn in an all-cash transaction

Published last May Monday 23, 2016
Bryan, Garnier & Co announces a €14.7m follow-on offering for Amoeba on Euronext with demand from European and US investors

Bryan, Garnier & Co announces a €14.7m follow-on offering for Amoeba on Euronext with demand from European and US investors

Published last May Tuesday 17, 2016

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities